Today: 8 June 2026
Browse Category

NYSE:RHHBY 17 July 2025 - 16 September 2025

Big Pharma’s Billion-Dollar Bet: Inside Eli Lilly’s $5B Virginia Factory and America’s New Drug Manufacturing Boom

Big Pharma’s Billion-Dollar Bet: Inside Eli Lilly’s $5B Virginia Factory and America’s New Drug Manufacturing Boom

Eli Lilly will invest $5 billion to build a 200,000-square-foot drug manufacturing plant in Goochland County, Virginia, creating 650 permanent jobs and 1,800 construction jobs. The facility will produce active pharmaceutical ingredients for cancer and autoimmune treatments. The project is part of Lilly’s $27 billion U.S. expansion plan. Virginia approved over $10 million in incentives to secure the site.
16 September 2025
·······
Biotech Breakthroughs, Pharma Power Moves & Health Shocks: News Roundup (Aug 18–19, 2025)

Biotech Breakthroughs, Pharma Power Moves & Health Shocks: News Roundup (Aug 18–19, 2025)

Genentech is ending its $2 billion cell therapy partnership with Adaptive Biotechnologies, citing cost-cutting but no safety issues. Kriya Therapeutics raised $313 million in Series D funding, one of the year’s largest biotech rounds. The FDA delayed Neurizon’s ALS drug trial review until October due to staffing shortages. Stealth BioTherapeutics has resubmitted its elamipretide application for Barth syndrome after two FDA rejections.
19 August 2025
····
AI Pathology Breakthrough: Roche’s Lung Cancer Diagnostic Makes FDA History

AI Pathology Breakthrough: Roche’s Lung Cancer Diagnostic Makes FDA History

Roche’s Ventana TROP2 (EPR20043) RxDx test became the first AI-powered diagnostic to receive FDA Breakthrough Device Designation in April 2025. The system uses digital pathology and AI to classify NSCLC tumors as TROP2-positive or negative, guiding use of Datopotamab deruxtecan. In a retrospective analysis, TROP2-positive patients saw a 43% lower risk of progression or death with the drug versus chemotherapy.
17 July 2025
·

Stock Market Today

  • Broadcom Stock Hits Historic Buy Opportunity Amid AI Growth Forecast
    June 8, 2026, 5:11 PM EDT. Broadcom (NASDAQ:AVGO) reported strong Q2 fiscal 2026 results with revenue up 48% year-over-year to $22.2 billion and AI semiconductor revenue soaring 143% to $10.8 billion. Despite this, shares dropped 20% from recent highs, trading near $398. Mizuho analysts forecast a surge in tensor processing unit (TPU) sales, projecting over 35 million units by 2028, driven by hyperscaler demand and OpenAI's expansion. This could generate $300 billion in revenue from Google-related TPU work alone. Broadcom's AI revenue is expected to climb from $56 billion in FY 2026 to $170 billion in FY 2028. The pullback is seen as a significant buying opportunity given the firm's strong AI semiconductor position and custom silicon momentum.

Latest articles

IonQ Jumps as Quantum IPO Rush Sets Wall Street Benchmark

IonQ Jumps as Quantum IPO Rush Sets Wall Street Benchmark

8 June 2026
IonQ surged 10.5% to $62.77, outpacing quantum peers after Quantinuum’s $1.68 billion Nasdaq IPO gave investors a new benchmark for trapped-ion quantum stocks; IonQ’s rally follows its May guidance raise and soaring revenue, but losses and a long commercialization timeline remain key risks.
Snap Shares Climb as Debt Markets Send Signal

Snap Drops Again as Wall Street Stays Wary

8 June 2026
Snap plunged 2.1% to $5.64, underperforming a tech rebound, as investors weighed improved cash flow and a recent S&P credit upgrade against ongoing ad-market pressure, cost cuts, and spending on Specs; the stock’s weakness stood out as peers like Pinterest gained, highlighting market doubts about Snap’s ability to sustain growth amid tough competition and uncertain ad budgets.
Dow Drops After Hours, AI Rally Sidesteps Blue Chips

Dow Drops After Hours, AI Rally Sidesteps Blue Chips

8 June 2026
The Dow Jones fell 104.70 points, or 0.21%, to 50,762.08 as tech and chip stocks rebounded sharply, with the Philadelphia SE Semiconductor Index up 6.2% after Friday’s $1 trillion selloff; Apple dropped 1.4% despite its AI event, and investors now await Wednesday’s inflation data and Middle East energy risks as the next key tests for the market’s fragile rebound.
Nasdaq rises as AI names find support after market selloff

Nasdaq rises as AI names find support after market selloff

8 June 2026
Nasdaq surged 1.27% as investors snapped up AI and chip stocks after Friday’s rout, with the Philadelphia Semiconductor Index jumping 6.2%; Citigroup hiked its S&P 500 year-end target to 8,100 on AI demand, but Goldman Sachs warned strong jobs data makes a Fed rate hike more plausible, posing risks to growth stocks if inflation surprises.
Go toTop